Earnings Feed
Start Free
NovoCure Ltd·4

Jul 6, 4:12 PM ET

Danziger Asaf 4

4 · NovoCure Ltd · Filed Jul 6, 2023

Insider Transaction Report

Form 4
Period: 2023-06-30
NovoCure LtdNVCR
Danziger Asaf
Director
Transactions
  • Award

    Ordinary Shares

    2023-06-30$35.28/sh+367$12,948→ 13,989 total
Footnotes (2)
  • [F1]The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of January1, 2023 through June 30, 2023. This transaction is also exempt under Rule 16b-3(c).
  • [F2]In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on June 30, 2023.

Documents

2 files